https://www.bioeclipse.com/2018/08/09/bioeclipse-looks-to-synergistic-therapies-to-topple-stubborn-cancers/ 2020-01-11T00:55:05+00:00 monthly 0.2 https://www.bioeclipse.com/2018/10/18/bioeclipse-therapeutics-honored-by-goldman-sachs-for-entrepreneurship/ 2020-01-09T21:28:09+00:00 monthly 0.2 https://www.bioeclipse.com/2019/06/24/bioeclipse-therapeutics-announces-appointment-of-new-directors-and-series-a-1-financing/ 2020-01-09T20:31:46+00:00 monthly 0.2 https://www.bioeclipse.com/2020/04/28/bioeclipse-receives-fda-clearance-of-investigational-new-drug-application-for-crx100/ 2020-04-28T21:11:31+00:00 monthly 0.2 https://www.bioeclipse.com/2020/05/01/bioeclipse-therapeutics-more-than-just-a-story-of-rebranding/ 2020-05-04T17:52:59+00:00 monthly 0.2 https://www.bioeclipse.com/2020/05/19/bioeclipse-therapeutics-announces-move-to-new-corporate-headquarters-in-mountain-view-ca/ 2020-05-20T02:52:36+00:00 monthly 0.2 https://www.bioeclipse.com/2020/07/01/a-small-biopharmas-view-of-working-with-cros/ 2020-07-06T18:19:59+00:00 monthly 0.2 https://www.bioeclipse.com/2020/07/31/the-benefit-of-having-a-highly-engaged-editorial-advisory-board/ 2020-08-04T01:58:59+00:00 monthly 0.2 https://www.bioeclipse.com/2020/09/25/accelerating-your-biopharma-startups-path-to-the-clinic/ 2020-09-30T22:50:31+00:00 monthly 0.2 https://www.bioeclipse.com/2020/10/22/designing-immunotherapies-that-can-overcome-recurrence-and-resistance/ 2020-10-27T17:56:06+00:00 monthly 0.2 https://www.bioeclipse.com/2020/12/21/bioeclipse-initiates-enrollment-in-phase-1-dose-escalation-clinical-trial-for-crx100/ 2020-12-22T01:40:50+00:00 monthly 0.2 https://www.bioeclipse.com/2021/01/19/bioeclipse-initiates-enrollment-in-phase-1-dose-escalation-clinical-trial-for-crx100-at-honorhealth-research-institute/ 2025-03-25T18:33:31+00:00 monthly 0.2 https://www.bioeclipse.com/2022/01/04/discover-5-top-pharma-startups-tackling-ovarian-cancer/ 2022-02-03T20:37:05+00:00 monthly 0.2 https://www.bioeclipse.com/2022/01/07/72-top-san-francisco-therapeutics-companies-and-startups-of-2021/ 2022-02-03T20:38:43+00:00 monthly 0.2 https://www.bioeclipse.com/2022/01/26/bioeclipse-therapeutics-appoints-new-board-member-and-names-interim-cfo/ 2025-03-25T18:32:12+00:00 monthly 0.2 https://www.bioeclipse.com/2022/04/26/bioeclipse-therapeutics-awarded-almost-8-million-grant-by-california-institute-for-regenerative-medicine-cirm-to-fund-ongoing-phase-1-crx100-cancer-immunotherapy-clinical-trial/ 2022-08-24T21:32:38+00:00 monthly 0.2 https://www.bioeclipse.com/2024/03/19/crx100-elicits-activity-is-well-tolerated-in-recurrent-platinum-resistant-ovarian-cancer/ 2024-04-17T21:34:51+00:00 monthly 0.2 https://www.bioeclipse.com/2024/04/09/top-50-women-leaders-of-san-jose-for-2024/ 2025-03-25T18:36:30+00:00 monthly 0.2